Stock Price
193,700.00
Daily Change
-2,100.00 -1.07%
Monthly
-5.05%
Yearly
18.76%
Q2 Forecast
184,597.56

Celltrion reported 50.09 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Akebia Therapeutics 1.63K 1.6K Dec/2025
Celltrion 50.09 23.24 Sep/2025
Dianthus Therapeutics 3.8 1.53 Sep/2024
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
IQVIA Holdings 26.59 2.03 Dec/2025
Moderna 27.22 14.51 Jun/2023
Organon & Co 3.75 0.87 Dec/2025
Revvity 49.87 16.58 Dec/2025
Tectonic Therapeutic 4.01 0.63 Mar/2024
Viatris 10.4 11.84 Sep/2025